Furthermore, this dose range is comparable to the optimal clinical dose of the similar sized fluorescent peptide OTL-38 for intraoperative fluorescence imaging of FRα-positive ovarian cancer: 12.5 to 50 μg/kg [8]. The gene discussed is FOLR1; the disease is ovarian cancer.